Moneycontrol
HomeNewsBusinessStocksDr Reddys completes acquisition of US penicillin facility
Trending Topics

Dr Reddys completes acquisition of US penicillin facility

Dr Reddys Laboratories touched an intraday high of Rs 1,644.65 and an intraday low of Rs 1,616. At 11:12 hrs the share was quoting at Rs 1,632.50, up Rs 34.10, or 2.13%. The company has announced completion of the acquisition of US penicillin facility and products from GlaxoSmithKline.

March 30, 2011 / 11:17 IST
Story continues below Advertisement

Dr Reddys Laboratories touched an intraday high of Rs 1,644.65 and an intraday low of Rs 1,616. At 11:12 hrs the share was quoting at Rs 1,632.50, up Rs 34.10, or 2.13%.


The company has announced completion of the acquisition of US penicillin facility and products from GlaxoSmithKline.
 
It was trading with volumes of 115,991 shares. In the previous trading session, the share closed up 3.13% or Rs 48.55 at Rs 1,598.40.

Share Price Movement During The Last 12 Months
PeriodPriceLatest PriceGain/Loss (Rs.)% Gain/Loss
3-Days1548.151632.5084.355.45
5-Days1556.851632.5075.654.86
7-Days1533.501632.5099.006.46
15-Days1597.401632.5035.102.20
1-Month1546.001632.5086.505.60
3-Month1693.601632.50-61.10-3.61
6-Month1459.301632.50173.2011.87
9-Month1455.101632.50177.4012.19
1-Year1268.501632.50364.0028.70

Story continues below Advertisement
first published: Mar 30, 2011 11:13 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!